Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10637/10822New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.
| Título : | New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes. |
| Autor : | Rangasamy, Loganathan Pascual-Teresa Fernández, Beatriz de. Zapico Rodríguez, José María. Ramos González, Ana. Ortín Remón, Irene Coderch Boué, Claire. |
| Materias: | Dinámica molecular.; Drogas de objetivos múltiples.; Multi-target drugs.; Dual inhibitors. |
| Resumen : | Four potent CK2 inhibitors derived from CX-4945 are described. They are provided also of nanomolar activity against HDAC1, therefore having promising utility as dual-target agents for cancer. The linker length between the hydroxamic acid and the CX-4945 scaffold plays an important role in dictating balanced activity against the targeted enzymes. The seven-carbon linker (compound 15c) was optimal for inhibition of both CK2 and HDAC1. Remarkably, 15c showed 3.0 and 3.5 times higher inhibitory activity than the reference compounds CX-4945 (against CK2) and SAHA (against HDAC1), respectively. Compound 15c exhibited micromolar activity in cell-based cytotoxic assays against multiple cell lines. |
| Descripción : | ACS Medicinal Chemistry Letters, ISSN 1948-5875, 2020, 11, 5, 713-719. |
| URI : | http://hdl.handle.net/10637/10822 |
| Derechos: | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
| Fecha de publicación : | 9-jun-2020 |
| Centro : | Universidad San Pablo-CEU |
| Aparece en las colecciones: | Facultad de Farmacia |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.